pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Rare Disease · news · pharmadog
← back to Rare Disease
News · Rare Disease
853
stories
Aug 5, 26
Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms
biospace
Aug 5, 26
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
stat
Aug 5, 26
STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds
stat
Aug 5, 26
4 potential biotech M&A targets, plus a pretty sure bet from J&J
biospace
Aug 4, 26
Blank Slate Creamery Issues Allergy Alert on Undeclared Egg in Vegan Non-Dairy Frozen Dessert Coconut Fudge Sandwiches
fda recalls
Aug 4, 26
STAT+: Startup promising to scale custom CRISPR therapies abruptly scraps plans
stat
Aug 4, 26
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
Aug 4, 26
STAT+: Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more
stat
Aug 4, 26
STAT+: The latest orphan drug exemptions may not be warranted, analysis finds
stat
Aug 4, 26
Merck's anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in SSc-ILD
endpoints
Aug 3, 26
BioNTech taps Sobi executive Oelkers as its next CEO
biopharma dive
Aug 3, 26
Boticelli Foods Recalls Bettergoods Pistachio Nut Butter Because of Possible Health Risk
fda recalls
Aug 3, 26
BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotech
biospace
Aug 3, 26
Amgen hit with cybersecurity breach, patient data affected
biospace
Aug 3, 26
Heart transplant candidates fail if they get too weak. New program tries inpatient prehab
stat
Aug 3, 26
STAT+: Are AI scribes useful tools in medical education, or a crutch that imperils learning?
stat
Aug 3, 26
Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls out
biospace
Aug 3, 26
5 companies advancing ATTR assets in the wake of Wainua’s fail
biospace
Aug 3, 26
Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea
fiercebiotech
Jul 31, 26
Capricor CEO won’t rule out legal action against FDA after negative adcomm
biospace
Jul 31, 26
Moderna maintains 10% growth target despite Phase 3 norovirus miss
biospace
Jul 31, 26
Alnylam absorbs $10.8B blowback after cutting full-year guidance for TTR franchise
biospace
Jul 31, 26
UniQure welcomes possible adcomm for Huntington’s asset as regulatory ‘jitters’ spread through biopharma
biospace
Jul 31, 26
Federal government could improve infectious disease monitoring, says federal government
stat
Jul 31, 26
Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
fiercebiotech
Jul 31, 26
Opinion: Limb girdle muscular dystrophy patients face a maddening reality
stat
Jul 30, 26
Alnylam plunges as earnings deliver ‘one-two punch’
biopharma dive
Jul 30, 26
Capricor’s data clash and a fugitive in the C-suite
stat
Jul 30, 26
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
Jul 30, 26
STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more
stat
← prev
page 16 of 29
next →
